中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
20期
13-14
,共2页
晏廷亮%张帆%崔道林%方杰%龚蕾
晏廷亮%張帆%崔道林%方傑%龔蕾
안정량%장범%최도림%방걸%공뢰
益生菌%美沙拉嗪%炎症性肠病
益生菌%美沙拉嗪%炎癥性腸病
익생균%미사랍진%염증성장병
Probiotics%Mesalazine%Inflammatory bowel disease
目的:观察美沙拉嗪联合益生菌对炎症性肠病大鼠血清中L-6、TNF-α和IFN-γ含量的影响,并初步探讨该方法治疗炎症性肠病的作用机制。方法:将40只雄性SD大鼠随机分为四组,即正常对照组、模型组、美沙拉嗪组和美沙拉嗪益生菌联合组,最后各组大鼠取血,应用ELISA法检测血清中IL-6、TNF-α和IFN-γ含量。结果:美沙拉嗪联合益生菌组IL-6、TNF-α和IFN-γ含量的表达均明显低于模型组(P<0.05)。结论:美沙拉嗪联合益生菌在缓解肠道炎症中发挥着重要作用。
目的:觀察美沙拉嗪聯閤益生菌對炎癥性腸病大鼠血清中L-6、TNF-α和IFN-γ含量的影響,併初步探討該方法治療炎癥性腸病的作用機製。方法:將40隻雄性SD大鼠隨機分為四組,即正常對照組、模型組、美沙拉嗪組和美沙拉嗪益生菌聯閤組,最後各組大鼠取血,應用ELISA法檢測血清中IL-6、TNF-α和IFN-γ含量。結果:美沙拉嗪聯閤益生菌組IL-6、TNF-α和IFN-γ含量的錶達均明顯低于模型組(P<0.05)。結論:美沙拉嗪聯閤益生菌在緩解腸道炎癥中髮揮著重要作用。
목적:관찰미사랍진연합익생균대염증성장병대서혈청중L-6、TNF-α화IFN-γ함량적영향,병초보탐토해방법치료염증성장병적작용궤제。방법:장40지웅성SD대서수궤분위사조,즉정상대조조、모형조、미사랍진조화미사랍진익생균연합조,최후각조대서취혈,응용ELISA법검측혈청중IL-6、TNF-α화IFN-γ함량。결과:미사랍진연합익생균조IL-6、TNF-α화IFN-γ함량적표체균명현저우모형조(P<0.05)。결론:미사랍진연합익생균재완해장도염증중발휘착중요작용。
To observe the effect of combined treatment of Mesalamine and Probiotics in IL-6, TNF-α and IFN-γ of the rats with Inflammatory bowel disease,and to explore the mechanism of the treatment for inflammatory bowel disease.Method:40 male SD rats were randomly divided into four groups,namely normal control group,model group,Mesalamine group and the combined group.IL-6,TNF-αand IFN-γin the serum of rats were detected by ELISA method.Result:The expression of IL-6,TNF-αand IFN-γin the combined group were significantly lower than those in the model group(P<0.05).Conclusion:The combined treatment of Mesalamine and Probiotics plays an important role in alleviating intestinal inflamm.